GlassScriptPhysician profile
Ginger L Urbaniak
NPI 1124448014
$12,254.53
in general payments reported to CMS, 2019-2025
15 companies · $2,102 in 2025
The $2,102 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $779 · 2020: $174 · 2021: $222 · 2022: $1,230 · 2023: $2,915 · 2024: $4,832 · 2025: $2,102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,349 · Consulting Fee: $1,800 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,800 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,348.99 |
| Consulting Fee | $1,800.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,800.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $900.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solta Medical, A Division of Bausch Health US, LLC | $4,800.08 | 2020-2025 | Clear+Brilliant, Clear & Brilliant |
| Merz North America, INC. | $3,169.41 | 2019-2025 | Xeomin |
| Abbvie INC. | $1,040.30 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Mentor Worldwide LLC | $755.67 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Galderma Laboratories, L.P. | $563.67 | 2019-2025 | Dysport |
| Sientra, INC. | $502.09 | 2022 | |
| Integra Lifesciences Corporation | $437.52 | 2023-2025 | Durasorb Monofilament Mesh, Integra, Surgimend |
| Allergan, INC. | $411.93 | 2019-2022 | |
| Tela Bio, INC. | $361.03 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Musculoskeletal Transplant Foundation INC. | $110.44 | 2024 | |
| Heron Therapeutics, INC. | $30.81 | 2022 | |
| Davol INC. | $28.28 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $17.49 | 2022 | |
| Smith+Nephew, INC. | $14.15 | 2022 | |
| Kci USA, INC. | $11.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ginger Urbaniak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.